期刊文献+

DECAY ACCELERATING FACTOR AND COLORECTAL CANCER

DECAY ACCELERATING FACTOR AND COLORECTAL CANCER
下载PDF
导出
摘要 Objective: To review the significance of decay accelerating factor (DAF) in the colorectal cancer, we searched the data from PubMed and selected the related articles for review. It was found that DAF were expressed in the adenomas and adenocarcinoma of colorectal tissues. The release of DAF in the stool of the patients was also detectable. It increased more significantly in the stool of patients with colorectal cancer than other gastrointestinal cancer. Its detection by ELISA method may render a good test for the noninvasive diagnosis of colorectal cancer. It can be concluded that DAF is expressed extensively in colorectal cancer. And the detection of DAF released in the stool of colorectal cancer patients may be a good noninvasive method for the diagnosis of colorectal cancer. Objective: To review the significance of decay accelerating factor (DAF) in the colorectal cancer, we searched the data from PubMed and selected the related articles for review. It was found that DAF were expressed in the adenomas and adenocarcinoma of colorectal tissues. The release of DAF in the stool of the patients was also detectable. It increased more significantly in the stool of patients with colorectal cancer than other gastrointestinal cancer. Its detection by ELISA method may render a good test for the noninvasive diagnosis of colorectal cancer. It can be concluded that DAF is expressed extensively in colorectal cancer. And the detection of DAF released in the stool of colorectal cancer patients may be a good noninvasive method for the diagnosis of colorectal cancer.
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2004年第1期73-77,共5页 中国癌症研究(英文版)
关键词 DAF Glycosyl-phosphatidylinositol (GPI) anchor Colorectal cancer DIAGNOSIS DAF Glycosyl-phosphatidylinositol (GPI) anchor Colorectal cancer Diagnosis
  • 相关文献

参考文献31

  • 1[1]Reid KBM, Bently DR, Campbell RD, et al. Complement system protein which interact with C3borC4b. A superfamily of structurally related proteins [J].Immunol Today 1986; 7:230.
  • 2[2]Lachmann PJ. Protection against complement lysis [J].Biochem Soc Trans 1990; 18:1159-60.
  • 3[3]Caras IW, Davitz MA, Rhee L, et al. Cloning of decayaccelerating factor suggests novel use of splicing to generate two proteins [J]. Nature 1987; 325:545-9.
  • 4[4]Nicholson Weller A, Burge J, Fearon DT, et al. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system [J]. J Immunol 1982; 129:184-9.
  • 5[5]Pangburn MK, Shreiber RD, Muller-Eberhanrd HJ, et al.Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria [J]. Proc Natl Acad Sci USA 1983;80:5430-4.
  • 6[6]Ferguson MA. The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and thecontributions of trypanosome research [J]. J Cell Sci 1999; 1 12:2799-809.
  • 7[7]Hirose S, Mohney RP, Mutka SC, et al. Derivation and characterization of glycoinositol-phospholipid anchordefective human K562 cell clones [J]. J Biol Chem 1992; 267:5272-8.
  • 8[8]Mohney RP, Knez JJ, Ravi L, et al. Glycoinositol phospholipid anchor-defective K562 mutants with biochemical lesions distinct from those in Thy-l- murine lymphoma mutants [J]. J Biol Chem 1994; 269:6536-42.
  • 9[9]Tiede A, Bastisch I, Schubert J, et al. Biosynthesis of glycosylphosphatidylinositols in mammals and unicellular microbes [J]. Biol Chem 1999; 380:503-23.
  • 10[10]Udenfriend S, Kodukula K. How glycosylphosphatidylinositol-anchored membrane proteins are made [J].Annu Rev Biochem 1995; 64:563-91.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部